Immunosuppressive Signature of Cutaneous Mycobacterium ulcerans Infection in the Peripheral Blood of Patients with Buruli Ulcer Disease
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Buruli ulcer disease (BUD) is an emerging human disease caused by infection with Mycobacterium ulcerans, which leads to the development of necrotic skin lesions. The pathogenesis of the ulcer is closely associated with the production of mycolactone, a diffusible cytotoxin with immunomodulatory properties. To identify immunological correlates of BUD, we performed a broad screen of inflammatory mediators in serum samples and stimulated whole-blood supernatants of patients. We found that patients with active ulcers displayed a distinctive profile of immune suppression, marked by the down-modulation of selected chemokines and an impaired capacity to produce Th1, Th2, and Th17 cytokines on stimulation with mitogenic agents. These immunological defects were induced early in the disease and resolved after anti-BUD therapy, establishing their association with the presence of M. ulcerans. Interestingly, some of the defects in cytokine and chemokine response could be mimicked in vitro by incubation of CD4(+) peripheral blood lymphocytes with mycolactone. Our findings support the hypothesis that mycolactone contributes to bacterial persistence in human hosts by limiting the generation of adaptive cellular responses. Moreover, we identified immunological markers of BUD, which may be helpful for confirmatory diagnosis of the disease and, especially, for monitoring the response to antibiotic treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mycolactone: A Polyketide Toxin from Mycobacterium ulcerans Required for Virulence
George, K. M., Chatterjee, D., Gunawardana, G., Welty, D., Hayman, J., Lee, R., & Small, P. L. C. (1999) · Science · doi:10.1126/science.283.5403.854 · Cited by 641
George, K. M., Pascopella, L., Welty, D. M., & Small, P. L. C. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.877-883.2000 · Cited by 256
Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans
Demangel, C., Stinear, T. P., & Cole, S. T. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2077 · Cited by 197 · cited 2×
“Patients who have BUD with active ulcers also show reduced systemic lymphoproliferative and IFN-g responses [1].”
BackgroundSelf-citationMycolactone inhibits monocyte cytokine production by a posttranscriptional mechanism
Simmonds, R. E., Lali, F. V., Smallie, T., Small, P. L. C., & Foxwell, B. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802294 · Cited by 106 · cited 1×
“matory cytokines, without loss of cell viability [11–14].”
Background
Cited by
Hall, B. S., Hill, K., McKenna, M., Ogbechi, J., High, S., Willis, A. E., & Simmonds, R. E. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004061 · Cited by 162
“S3B and C), especially since others have previously shown that both are mycolactone targets in other systems [16,18].”
BackgroundBuruli Ulcer: Advances in Understanding Mycobacterium ulcerans Infection
Walsh, D. S., Portaels, F., & Meyers, W. M. (2011) · Dermatologic Clinics · doi:10.1016/j.det.2010.09.006 · Cited by 88
Hall, B., & Simmonds, R. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130133 · Cited by 52
“This may explain the anergy that has been reported in patients, where their T cells no longer respond to mycobacterial antigens after exposure [45], and contribute to the reduced Th1/Th2/Th17 responses seen in whole blood-restimulations [44].”
BackgroundInfluential
Metadata
- Authors
- Phillips, R., Sarfo, F. S., Guenin‐Macé, L., Decalf, J., Wansbrough‐Jones, M., Albert, M. L., & Demangel, C.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-12
- Volume
- 200
- Issue
- 11
- Pages
- 1675-1684
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2108317365
- Cited by
- 87
- References
- 4
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.